ReShape Lifesciences RSLS 深 沪
已收盘 08-01 16:00:00 美东时间
2.49
+0.050
+2.05%
华盛通- 最 高2.49
- 今 开2.44
- 成交量 8.89万股
- 最 低 2.35
- 昨 收 2.44
- 总市值 594.11万
- 52周最高 303.2475
- 市盈率 静 --
- 换手率 3.72%
- 52周最低 2.23
- 委 比 20.42%
- 总股本 238.60万
- 历史最高 4567500.00
- 量 比 0.26
- 振 幅 5.74%
- 历史最低 2.35
- 每 手 1
- 风险率 83.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
ReShape Lifesciences conducted a Special Meeting of Stockholders, partially adjourning to seek additional proxies for Proposal 2 (asset sale to Ninjour Health) and Proposal 3 (charter amendment for merger with Vyome). Other merger-related proposals were approved. CEO Paul F. Hickey emphasized that approvals are critical for the merger. The meeting will resume on August 7, 2025, at 11:30 a.m. ET. Stockholders are encouraged to vote FOR both propos...
07-24 20:39
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
ReShape Lifesciences will host its first Lap-Band® Surgeon Summit from August 1-3, 2025, in Nashville, featuring Dr. Christine Ren-Fielding as director. The event will focus on the benefits of the Lap-Band® System, including the new 2.0 FLEX, and advancements in GLP-1 therapies. The company aims to enhance patient outcomes and expand access to these weight management tools through collaboration with leading surgeons.
07-22 12:31
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025
ReShape Lifesciences announced a special stockholder meeting on July 24, 2025, to vote on a merger with Vyome Therapeutics and the sale of assets to Biorad Medisys. The board unanimously recommends approval of Proposals 1, 2, and 3, supported by proxy advisory firms ISS and Glass Lewis. CEO Paul F. Hickey emphasized the importance of shareholder votes to maximize value through the transactions. Vyome aims to leverage its pipeline and US-India inn...
07-21 18:10
'ReShape Lifesciences Granted U.S. Patent Related To An Intragastric Balloon System'
https://reshapelifesciences.gcs-web.com/news-releases/news-release-details/reshape-lifesciencesr-granted-us-patent-related-intragastric
07-08 22:26
ReShape Lifesciences Loans $200K to Vyome Therapeutics
ReShape Lifesciences ( ($RSLS) ) has shared an announcement. On June 27, 2025, ...
07-04 04:33
ReShape Lifesciences Granted U.S. Patent 12,350,179 Entitled "Intragastric Device."
The patent, related to the Company's application 18/241,151 and notice of allowance received in April, covers claims for an intragastric balloon system, comprising a swallowable capsule with a self-sealing fill valve and
07-01 20:34
ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System
ReShape Lifesciences® announced the issuance of U.S. Patent 12,350,179, covering an intragastric balloon system with a swallowable capsule, self-sealing fill valve, and degradable release valve. The patent, set to be issued on July 8, 2025, provides protection until at least January 2031 and strengthens the company's intellectual property portfolio, which now includes over 160 issued and pending patents. The company also noted its agreement to se...
07-01 12:31
ReShape Lifesciences regains Nasdaq compliance
ReShape Lifesciences (NASDAQ:RSLS) has regained compliance with Nasdaq requiring at least $2.5M in stockholders’ equity. Source: Press release More on ReShape Lifesciences ReShape Lifesciences Inc. (R...
06-27 21:53
ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
ReShape Lifesciences Inc. (Nasdaq: RSLS) announced on June 23, 2025, that it has regained compliance with Nasdaq's stockholders' equity requirement, resolving its listing matter. Previously, on May 28, 2025, Nasdaq notified the Company of its non-compliance with the $2.5 million stockholders' equity rule, risking delisting. To address this, ReShape sold shares in two offerings, raising total proceeds of $6,279,074, ensuring it met the equity requ...
06-27 13:01
BGMC International Advances Debt Restructuring with RSLS Holders’ Approval
BGMC International Ltd. ( ($HK:1693) ) has shared an announcement. BGMC Interna...
06-26 22:42
